As part of the settlement announced this week, Boehringer agreed to pay the sum in back pay and interest to the women at the facility that makes biological animal vaccines.
The Labor Department alleges the employees — who work as scientists, technicians and technical administrators — were paid less base compensation than male employees at the company’s animal health unit. According to STAT, the alleged wage discrimination occurred after an audit in 2015, when Boehringer Ingelheim was a federal contractor.
In addition to back pay, Boehringer Ingelheim has also agreed to ensure the company’s pay policies and procedures are free from discrimination and provide training to workers who oversee compensation decisions, the Labor Department said.
Boehringer Ingelheim cooperated with federal officials to resolve the issues, does not admit liability and denies the allegations, according to the Labor Department.
More articles on legal and regulatory issues:
Ex-CEO gets 3 years in prison for healthcare fraud
Defamation lawsuit accuses New Jersey hospital of ‘bowing to Twitter mob’
Ex-New Jersey hospital workers charged with embezzlement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
